Glaxo replaces ViiV Healthcare chief as executive shuffle continues
The executive exodus at GlaxoSmithKline is continuing—and so is the rise of women to the company’s top ranks. The British pharma giant announced that Dominique Limet, head of HIV unit ViiV Healthcare, would step down at the end of March 2017—the same month the company will bid farewell to longtime CEO Andrew Witty. He’ll be replaced by Deborah Waterhouse, who currently serves as GSK’s SVP of primary care, and VP of U.S. primary care sales Cheryl MacDiarmid will step in for Waterhouse.
Lilly nets best-case Jardiance nod from FDA
Eli Lilly snagged a new indication for SGLT2 contender Jardiance, meaning ...
